Bursa Yüksek İhtisas Hastanesi
Bursa, 16330, Turkey (Türkiye)
NCT Number: NCT01136837
To investigate the prognostic significance of a fragmented QRS (fQRS) complex in a patient who had undergone primary percutaneous coronary intervention (PCI).
Looking for future studies?
Notify Me18 year–80 year
All sexes
Observational
Bursa, 16330, Turkey (Türkiye)
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
the presence of a fQRS at 48 hours after primary PCI is a significant parameter in predicting adverse cardiovascular events;
the presence of a fQRS is a more sensitive and specific parameter in predicting development of adverse cardiovascular events than Q wave and QRS distortion; and compared to Q wave, fQRS correlated more significantly with the presence of a scar
Bursa Postgraduate Hospital
Other
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT05605288
Arterial Occlusive Diseases, Arteriosclerosis
Charleroi, Belgium
View Trial DetailsNCT06930989
Apnea, Cardiovascular Diseases
Gothenburg, VGR, Sweden
View Trial DetailsNCT05329155
Cardiovascular Diseases, Heart Diseases
Wuhan, Hubei, China
View Trial DetailsNCT01924442
All Cause Mortality, Arterial Occlusive Diseases
Northport, New York, United States
View Trial Details